Combination Study of Antibiotics With Enzalutamide (PROMIZE)

Conditions: Metastatic Castration-Resistant Prostate Cancer (mCRPC) Interventions: Drug: Enzalutamide 40mg; Drug: Amoxicillin 500mg; Drug: Metronidazole 400mg; Drug: Vancomycin 125mg; Drug: Ciprofloxacin 500g Sponsors: Institute of Cancer Research, United Kingdom; Prostate Cancer Foundation Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials